Faculty profile

Hugues Allard-Chamard

ResearcherRhumatologieUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Hugues Allard-Chamard

Researcher

Rhumatologie

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
32 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Abatacept Autoimmunity B Cells Common Variable Immunodeficiency Immunodeficiency Inflammatory Arthritis Microrna Cytotoxic T Lymphocyte-Associated Protein 4 (Ctla4)

Latest papers

Patient-reported satisfaction following a switch from reference denosumab to biosimilar denosumab: real-world data from a Canadian patient survey
Expert Opinion on Biological Therapy · 2026
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3
Journal of Rheumatology · 2026
Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).
Gut microbes · 2026

All 49 publications

Latest funding

Osteoclast-Related Cells as Biomarkers for Bone Homeostasis in Osteoporosis
CIHR · 2025 · Co-investigator
$581,400
Immunopathogenic mechanisms of IL-15 in intestinal inflammation
CIHR · 2024 · Co-investigator
$1,055,700
Tailored exercise interventions to improve the quality of life in individuals with post-COVID-19 condition: The impact on patient's functionality and their immune and plasma proteome parameters
CIHR · 2023 · Co-investigator
$100,000

All 9 grants and awards

49 publications.

Patient-reported satisfaction following a switch from reference denosumab to biosimilar denosumab: real-world data from a Canadian patient survey

Khan AA, Allard-Chamard H, Kazem M, Khan S, Ruban TN

Expert Opinion on Biological Therapy2026

DOI: 10.1080/14712598.2026.2703142

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3

Nikolic RPA, Agarwal A, Pardo JP, Akhavan P, Allard-Chamard H, Barber CEH, Barnabe C, Jamal S, Kuriya B, Legge A

Journal of Rheumatology2026

DOI: 10.3899/jrheum.2026-0228

Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).

Pasquier JC, Chaillet N, Plourde M, Boivin G, Hamelin MÈ, Allard-Chamard H, Piché A, Baron G, Laforest-Lapointe I, Généreux M, Mâsse B, Robitaille J, Beaulieu JF, Fülöp T, Bilodeau S, Ramanathan S

Gut microbes2026

DOI: 10.1080/19490976.2026.2699456 PMID: 42520140

Lessons from an early rheumatoid arthritis incident cohort.

Bykerk VP, Bartlett SJ, Schieir O, Boire G, Hitchon CA, Thorne C, Tin D, Haraoui B, Bessette L, Hazlewood G, Allard-Chamard H, Kuriya B, Valois MF, Pope JE, CATCH Investigators and Participants

Seminars in arthritis and rheumatism2026

DOI: 10.1016/j.semarthrit.2026.152992 PMID: 42247732

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Chowdhury MMH, Fontaine MN, Lord SE, Lucier JF, Allard-Chamard H, Ilangumaran S, Piché A, Dionne IJ, Ramanathan S

Frontiers in sports and active living2026

DOI: 10.3389/fspor.2026.1797346 PMID: 42294006

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.

Chowdhury MMH, Quenum AJI, Rioux-Perreault C, Lucier JF, Ilangumaran S, Piché A, Allard-Chamard H, Ramanathan S

Scientific reports2026

DOI: 10.1038/s41598-026-46180-y PMID: 41998026

CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.

Crespo Oliva CDC, Gerber Z, Jean D, Allard-Chamard H, Labrie M

Discovery immunology2026

DOI: 10.1093/discim/kyag007 PMID: 41960374

Longitudinal changes in patient characteristics as drivers of clinical outcomes in the Early Undifferentiated PolyArthritis (EUPA) cohort.

Carrier N, Marrugo J, Paudel ML, Roux S, Allard-Chamard H, de Brum-Fernandes AJ, Liang P, Boire G

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keaf650 PMID: 41358962

Stressful Life Events in the Year Prior to Diagnosis and Associations With Rheumatoid Arthritis Characteristics at Presentation and 1 Year Later.

Andersen NJ, Schieir O, Valois MF, Boire G, Tin D, Pope JE, Hitchon CA, Hazlewood GS, Thorne JC, Bessette L, Allard-Chamard H, Kuriya B, Bykerk VP, Bartlett SJ, CATCH Investigators

The Journal of rheumatology2026

DOI: 10.3899/jrheum.2025-0873 PMID: 41539730

Exploring the Genetic Landscape of Psoriatic Arthritis: A Narrative Review of Recent Genomic Studies.

Allard-Chamard H, Rahman P

The Journal of rheumatology2026First author

DOI: 10.3899/jrheum.2025-0273 PMID: 40750314

Something wrong or missing on this profile? Suggest a correction

Hugues Allard-Chamard

Research

Latest papers

Latest funding

Patient-reported satisfaction following a switch from reference denosumab to biosimilar denosumab: real-world data from a Canadian patient survey

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3

Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).

Lessons from an early rheumatoid arthritis incident cohort.

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Distinct plasma proteome signature at 3&#xa0;months post-COVID-19 infection irrespective of post-COVID condition.

CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.

Longitudinal changes in patient characteristics as drivers of clinical outcomes in the Early Undifferentiated PolyArthritis (EUPA) cohort.

Stressful Life Events in the Year Prior to Diagnosis and Associations With Rheumatoid Arthritis Characteristics at Presentation and 1 Year Later.

Exploring the Genetic Landscape of Psoriatic Arthritis: A Narrative Review of Recent Genomic Studies.

Frequent collaborators

Sheela Ramanathan

Sophie Roux

Glen Hazlewood

Subburaj Ilangumaran

Marilyne Labrie

Carol Hitchon

Isabelle Laforest-Lapointe

Julie Robitaille

Alfredo Menendez

Derek Allan Haaland

Ines Colmegna

Sasha Bernatsky

Marie Hudson

Proton Rahman

Sasha Bernatsky

Jean-Luc Parent

Guy Boivin

Janet Pope

Christian Iorio-Morin

Sabrina Hoa

Jason Karamchandani

Alain Piche

Jean-Paul Makhzoum

Sabrina Hoa

Carter Thorne

Jason Karamchandani

Marie-Claude Beaulieu

Aliya Khan

Margaret Larche

Arnav Agarwal

Anne-Claude Gingras

Peter Tugwell

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.